サイクリンT2
gov/pmc/articles/PMC162212/.
“Large-scale characterization of HeLa cell nuclear phosphoproteins”. Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. (2004). Bibcode: 2004PNAS..10112130B. doi:10.1073/pnas.0404720101. PMC 514446. PMID 15302935. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC514446/.
“Transcriptional activity and substrate recognition of cyclin T2 from P-TEFb”. Gene 343 (1): 173–9. (2004). doi:10.1016/j.gene.2004.08.027. PMID 15563843.
“The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription”. Mol. Cell 19 (4): 523–34. (2005).
“[Problem of occupational disability hazards]”. Lebensversicher Med 28 (3): 76–7. (1976). PMID 9544.
“Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b”. Virology 255 (1): 182–9. (1999). doi:10.1006/viro.1998.9589. PMID 10049833.
“Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation”. J. Mol. Biol. 288 (1): 57–69. (1999). doi:10.1006/jmbi.1999.2664. PMID 10329126.
“Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes”.